Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (701-710 of 721) with videos related to

Pageof 73
Sort By:
Thoracic Cancer|November 20, 2025
Pathologic Complete Response Predicts Long-Term Survival Following Neoadjuvant Induction Chemotherapy and Chemo-Radiotherapy in Stage-III Non-Small Cell Lung CancerMaja Guberina, Martin Metzenmacher, Christoph Pöttgen, et al.
The Lancet. Oncology|December 4, 2018
Consensus on molecular imaging and theranostics in prostate cancerStefano Fanti, Silvia Minozzi, Gerald Antoch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
AutoPET Challenge on Fully Automated Lesion Segmentation in Oncologic PET/CT Imaging, Part 2: Domain GeneralizationJakob Dexl, Sergios Gatidis, Marcel Früh, et al.
NPJ Digital Medicine|October 14, 2025
Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratificationKatarzyna Borys, Johannes Haubold, Julius Keyl, et al.
Nature Cancer|January 30, 2025
Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligenceJulius Keyl, Philipp Keyl, Grégoire Montavon, et al.
Nature Medicine|July 31, 2024
Cranioencephalic functional lymphoid units in glioblastomaCelia Dobersalske, Laurèl Rauschenbach, Yichao Hua, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE RegistryNika Guberina, Madeleine J Karpinski, Maja Guberina, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 23, 2021
An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastasesJad S Husseini, Bárbara Juarez Amorim, Angel Torrado-Carvajal, et al.
European Urology|May 3, 2025
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry StudyMadeleine J Karpinski, Kambiz Rahbar, Martin Bögemann, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2022
Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendationMarcus Unterrainer, Christophe M Deroose, Ken Herrmann, et al.
Pageof 73

Showing results (701-710 of 721) with videos related to

Sort By:
Pageof 73
Thoracic Cancer|November 20, 2025
Pathologic Complete Response Predicts Long-Term Survival Following Neoadjuvant Induction Chemotherapy and Chemo-Radiotherapy in Stage-III Non-Small Cell Lung CancerMaja Guberina, Martin Metzenmacher, Christoph Pöttgen, et al.
The Lancet. Oncology|December 4, 2018
Consensus on molecular imaging and theranostics in prostate cancerStefano Fanti, Silvia Minozzi, Gerald Antoch, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 30, 2025
AutoPET Challenge on Fully Automated Lesion Segmentation in Oncologic PET/CT Imaging, Part 2: Domain GeneralizationJakob Dexl, Sergios Gatidis, Marcel Früh, et al.
NPJ Digital Medicine|October 14, 2025
Leveraging Sarcopenia index by automated CT body composition analysis for pan cancer prognostic stratificationKatarzyna Borys, Johannes Haubold, Julius Keyl, et al.
Nature Cancer|January 30, 2025
Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligenceJulius Keyl, Philipp Keyl, Grégoire Montavon, et al.
Nature Medicine|July 31, 2024
Cranioencephalic functional lymphoid units in glioblastomaCelia Dobersalske, Laurèl Rauschenbach, Yichao Hua, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2026
Salvage Radiotherapy Confers an Overall Survival Advantage in Biochemical Recurrence of Prostate Cancer: Evidence from the International PROMISE RegistryNika Guberina, Madeleine J Karpinski, Maja Guberina, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 23, 2021
An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastasesJad S Husseini, Bárbara Juarez Amorim, Angel Torrado-Carvajal, et al.
European Urology|May 3, 2025
Updated Prostate Cancer Risk Groups by Prostate-specific Membrane Antigen Positron Emission Tomography Prostate Cancer Molecular Imaging Standardized Evaluation (PPP2): Results from an International Multicentre Registry StudyMadeleine J Karpinski, Kambiz Rahbar, Martin Bögemann, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2022
Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendationMarcus Unterrainer, Christophe M Deroose, Ken Herrmann, et al.
Pageof 73